The development and appraisal of a tool designed to find patients harmed by falsely labelled, falsified (counterfeit) medicines

• Hauptverfasser: Marija Anđelković (Verfasst von), Einar Björnsson (Verfasst von), Virgilio De Bono (Verfasst von), Nenad Dikić (Verfasst von), Katleen Devue (Verfasst von), Daniel Ferlin (Verfasst von), Miroslav Hanževački (Verfasst von), Freyja Jónsdóttir (Verfasst von), Mkrtich Shakaryan (Verfasst von), Sabine Walser (Verfasst von)
• Format: Buch
• Veröffentlicht: BMC, 2017-06-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Abstract Background Falsely labelled, falsified (counterfeit) medicines (FFCm's) are produced or distributed illegally and can harm patients. Although the occurrence of FFCm's is increasing in Europe, harm is rarely reported. The European Directorate for the Quality of Medicines & Heal...